About PolyActiva
PolyActiva is a company based in Melbourne (Australia) founded in 2010.. PolyActiva has raised $46.72 million across 4 funding rounds from investors including National Reconstruction Fund Corporation, Brandon Capital and Medical Research Commercialisation Fund. PolyActiva offers products and services including Prezia and PA5108 Ocular Implant. PolyActiva operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Melbourne, Australia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Polyactiva Pty Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$46.72 M (USD)
in 4 rounds
-
Latest Funding Round
$25.75 M (USD), Series C
May 30, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PolyActiva
PolyActiva offers a comprehensive portfolio of products and services, including Prezia and PA5108 Ocular Implant. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for precise and controlled drug delivery in eye diseases.
Implant that reduces intraocular pressure for glaucoma treatment.
Unlock access to complete
Funding Insights of PolyActiva
PolyActiva has successfully raised a total of $46.72M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $25.75 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $25.7M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series C - PolyActiva | Valuation | The National Reconstruction Fund Corporation | |
| Sep, 2018 | Amount | Series B - PolyActiva | Valuation |
investors |
|
| Feb, 2013 | Amount | Series B - PolyActiva | Valuation | Brandon Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PolyActiva
PolyActiva has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include National Reconstruction Fund Corporation, Brandon Capital and Medical Research Commercialisation Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage medical companies are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Seed & Early stage Life-Sciences focused VC Firm investing primarily in Australia
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PolyActiva
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PolyActiva
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Polyactiva Comparisons
Competitors of PolyActiva
PolyActiva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Polyactiva
Frequently Asked Questions about PolyActiva
When was PolyActiva founded?
PolyActiva was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is PolyActiva located?
PolyActiva is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Is PolyActiva a funded company?
PolyActiva is a funded company, having raised a total of $46.72M across 4 funding rounds to date. The company's 1st funding round was a Series B of $9.47M, raised on Jan 01, 2011.
What does PolyActiva do?
PolyActiva was founded in 2010 in Melbourne, Australia, within the biomedical sector. A technology platform for slow-release, site-specific drug delivery is utilized, featuring erodible implants produced from proprietary drug-polymer conjugates that fully degrade without residue. Biomedical products and delivery devices are being developed for glaucoma, endophthalmitis, and osteoarthritis, targeting direct treatment at affected sites.
Who are the top competitors of PolyActiva?
PolyActiva's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does PolyActiva offer?
PolyActiva offers Prezia and PA5108 Ocular Implant.
Who are PolyActiva's investors?
PolyActiva has 4 investors. Key investors include National Reconstruction Fund Corporation, Brandon Capital, Medical Research Commercialisation Fund, and Yuuwa Capital.